Tennessee BioResearch Product Faire™
Launched in 2016, the Precision Medicine Initiative aims to transform our understanding of the factors that contribute to health and disease. The National Institutes of Health (NIH) provided Vanderbilt University a $31.8M grant to be used for the Precision Medicine Initiative (PMI) program with a projected project end date of December 2022. Dr. Joshua Denny, MD, MS, is a Professor of Biomedical Informatics and Medicine as well as principal investigator (PI) of the Data and Research Center of the PMI “All of Us” Research program at Vanderbilt in Nashville, Tennessee.
By Dansan4444 - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=21419527
Dr. Denny is actively collecting biological samples from volunteers and as of January 25th, 2019 had 100,000 participants complete in-person visits. The NIH goal is to have at least one million volunteers from around the United States participate in the project in hopes of changing the “one-size-fits-all-approach” that most medical treatments are currently designed around. This large pool of data will hopefully allow medical professionals to take into account individual differences in people’s genes, environments and lifestyles to provide more personalized treatment(s). Advances in precision medicine are already transforming the way we treat diseases and various forms of cancer. New treatments are being optimized for each particular person and patients now routinely undergo molecular testing as part of patient care. The “All of Us” Research program will continue collecting data across the nation until 2022 and massive funding is being dispersed to keep the project moving forward.According to the National Science Foundation, Vanderbilt’s School of Medicine received over $700 million in Research & Development expenditures in 2017 ranking it the 31st best-funded university in the nation. Research is one of Vanderbilt University Medical Center’s core missions and they pride themselves on a uniquely collaborative culture where research in biomedicine and healthcare is touched upon by every school within the university.
Vanderbilt University Funding Facts:
Later this fall Biotechnology Calendar looks forward to hosting its 1st annual BioResearch Product Faire™ event at Vanderbilt where Professors, Graduate Students, Post Doctoral Candidates, Research Scientists, Grant Holders, Principal Investigators, Lab Managers and Pharmacists can network and learn about the latest science innovations. The event will take place Thursday October 3rd, 2019.
By Dansan4444 - Own work, CC0, https://commons.wikimedia.org/w/index.php?curid=15065944
If you are a lab supplier, attending the event will introduce your products and services to hundreds of researchers actively seeking the newest and latest technologies to aid their life science research. We hope you will join us at the upcoming Vanderbilt BioResearch Product Faire™ event.
The NIH has just announced that the Electronic Medical Records and Genomics (eMERGE) consortium of seven US medical research institutions has received an additional $25M in funding for Phase II of a series of projects to study how genetic information in patients' medical records can be used to improve their care. As genome sequencing becomes increasingly affordable and more widely done, translational research is needed to show physicians how they might respond to indicators of genetic predisposition to disease in their treatment programs. The eMERGE network was formed in 2007 "to develop, disseminate, and apply approaches to research that combine DNA biorepositories with electronic medical record (EMR) systems for large-scale, high-throughput genetic research," according to the National Human Genome Research Institute (NHGRI) branch of the NIH.
Tags: Mount Sinai School of Medicine, Northeast, Vanderbilt University, University of Washington, WA, Northwest, Translational Research, New York, MSSM, BioResearch Product Faire Event, Genomics, NY, NIH, Seattle, Biomedical Research Funding, Nashville TN, 2011